Eurofins Scientific SE (EPA: ERF)
France
· Delayed Price · Currency is EUR 45.37
-0.03 (-0.07%)
Nov 13, 2024, 9:18 AM CET
Eurofins Scientific SE Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 6,724 | 6,515 | 6,712 | 6,718 | 5,439 | 4,563 | Upgrade
|
| Revenue Growth (YoY) | 3.28% | -2.94% | -0.08% | 23.51% | 19.20% | 20.67% | Upgrade
|
| Cost of Revenue | 5,232 | 5,140 | 5,199 | 4,816 | 4,026 | 3,632 | Upgrade
|
| Gross Profit | 1,492 | 1,375 | 1,513 | 1,902 | 1,413 | 930.8 | Upgrade
|
| Selling, General & Admin | 13.1 | 13.1 | 0.8 | 0.7 | 0.6 | 1 | Upgrade
|
| Operating Expenses | 671.7 | 657.7 | 604.2 | 543.6 | 508.3 | 474.4 | Upgrade
|
| Operating Income | 820 | 717 | 908.7 | 1,358 | 904.4 | 456.4 | Upgrade
|
| Interest Expense | -141.3 | -123.4 | -91.6 | -87.4 | -103 | -96.5 | Upgrade
|
| Earnings From Equity Investments | 0.7 | 0.4 | 0.9 | 2 | 1.7 | 0.6 | Upgrade
|
| Currency Exchange Gain (Loss) | -7.3 | 11.2 | -32.9 | -17.9 | -4.7 | -2.9 | Upgrade
|
| Other Non Operating Income (Expenses) | 17.3 | 7.2 | -11.6 | -5.1 | 0.5 | 4.7 | Upgrade
|
| EBT Excluding Unusual Items | 689.4 | 612.4 | 773.5 | 1,250 | 798.9 | 362.3 | Upgrade
|
| Merger & Restructuring Charges | -1.6 | -15.1 | -8.7 | -16.9 | -59.7 | -56.3 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.9 | -1.8 | 141.4 | -0.1 | - | - | Upgrade
|
| Other Unusual Items | -181.3 | -172.3 | -126.2 | -176.1 | -44.9 | -34.5 | Upgrade
|
| Pretax Income | 504.6 | 423.2 | 780 | 1,057 | 694.3 | 271.5 | Upgrade
|
| Income Tax Expense | 128 | 115.5 | 174.2 | 273.6 | 153.9 | 76.3 | Upgrade
|
| Earnings From Continuing Operations | 376.6 | 307.7 | 605.8 | 783 | 540.4 | 195.2 | Upgrade
|
| Minority Interest in Earnings | 2.8 | 2.5 | 4.4 | -0.4 | -1 | - | Upgrade
|
| Net Income | 379.4 | 310.2 | 610.2 | 782.6 | 539.4 | 195.2 | Upgrade
|
| Preferred Dividends & Other Adjustments | 53.5 | 53.7 | 29.3 | 34.1 | 34.1 | 49.7 | Upgrade
|
| Net Income to Common | 325.9 | 256.5 | 580.9 | 748.5 | 505.3 | 145.5 | Upgrade
|
| Net Income Growth | -16.06% | -49.16% | -22.03% | 45.09% | 176.33% | -12.82% | Upgrade
|
| Shares Outstanding (Basic) | 193 | 193 | 193 | 192 | 186 | 178 | Upgrade
|
| Shares Outstanding (Diluted) | 196 | 198 | 199 | 201 | 196 | 187 | Upgrade
|
| Shares Change (YoY) | -0.86% | -0.55% | -0.80% | 2.40% | 5.04% | 1.91% | Upgrade
|
| EPS (Basic) | 1.69 | 1.33 | 3.02 | 3.91 | 2.71 | 0.82 | Upgrade
|
| EPS (Diluted) | 1.67 | 1.30 | 2.92 | 3.73 | 2.58 | 0.78 | Upgrade
|
| EPS Growth | -20.17% | -55.48% | -21.72% | 44.57% | 230.77% | -18.58% | Upgrade
|
| Free Cash Flow | 747.5 | 539.8 | 560.2 | 1,067 | 912.7 | 399.7 | Upgrade
|
| Free Cash Flow Per Share | 3.81 | 2.73 | 2.82 | 5.32 | 4.66 | 2.14 | Upgrade
|
| Dividend Per Share | 0.500 | 0.500 | 1.000 | 1.000 | 0.680 | 0.345 | Upgrade
|
| Dividend Growth | -50.00% | -50.00% | 0% | 47.06% | 97.10% | 19.79% | Upgrade
|
| Gross Margin | 22.19% | 21.10% | 22.54% | 28.31% | 25.97% | 20.40% | Upgrade
|
| Operating Margin | 12.20% | 11.01% | 13.54% | 20.22% | 16.63% | 10.00% | Upgrade
|
| Profit Margin | 4.85% | 3.94% | 8.65% | 11.14% | 9.29% | 3.19% | Upgrade
|
| Free Cash Flow Margin | 11.12% | 8.29% | 8.35% | 15.88% | 16.78% | 8.76% | Upgrade
|
| EBITDA | 1,308 | 1,187 | 1,353 | 1,748 | 1,274 | 795 | Upgrade
|
| EBITDA Margin | 19.45% | 18.22% | 20.15% | 26.02% | 23.43% | 17.42% | Upgrade
|
| D&A For EBITDA | 487.5 | 470.1 | 443.8 | 389.9 | 369.7 | 338.6 | Upgrade
|
| EBIT | 820 | 717 | 908.7 | 1,358 | 904.4 | 456.4 | Upgrade
|
| EBIT Margin | 12.20% | 11.01% | 13.54% | 20.22% | 16.63% | 10.00% | Upgrade
|
| Effective Tax Rate | 25.37% | 27.29% | 22.33% | 25.89% | 22.17% | 28.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.